These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2296407)

  • 21. [Reliability of cytodiagnosis from washings and free fluid in the staging and follow-up of ovarian tumors].
    Ciarmiello G; Sopracordevole F; Miotto E; Scarabelli C
    Minerva Ginecol; 1990; 42(1-2):11-4. PubMed ID: 2139923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic cancer. Cytologic study of peritoneal washings.
    Lei S; Kini J; Kim K; Howard JM
    Arch Surg; 1994 Jun; 129(6):639-42. PubMed ID: 8204039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of elastin staining in the assessment of peritoneal implants associated with ovarian serous borderline tumours.
    Stewart CJ; Brennan BA; Crook ML; Russell P
    Histopathology; 2007 Sep; 51(3):313-21. PubMed ID: 17727474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopic surgical staging of ovarian cancer.
    Childers JM; Lang J; Surwit EA; Hatch KD
    Gynecol Oncol; 1995 Oct; 59(1):25-33. PubMed ID: 7557611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Morphologic evaluation of glandular inclusions in the peritoneum in relation to the prognostic value of second look laparotomy in ovarian cancer].
    Dzikonski M; Fiedler B
    Zentralbl Gynakol; 1991; 113(1):49-52. PubMed ID: 1645490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis.
    Selvaggi SM
    Diagn Cytopathol; 2003 Jun; 28(6):335-41. PubMed ID: 12768641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contemporary surgical management of borderline ovarian tumors: a survey of the Society of Gynecologic Oncologists.
    Menzin AW; Gal D; Lovecchio JL
    Gynecol Oncol; 2000 Jul; 78(1):7-9. PubMed ID: 10873401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous image-guided fine-needle aspiration of peritoneal lesions.
    Layfield LJ; Gopez EV
    Diagn Cytopathol; 2003 Jan; 28(1):6-12. PubMed ID: 12508175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritoneal washing cytology at second-look laparotomy in cisplatin-treated ovarian cancer patients.
    Kudo R; Takashina T; Ito E; Mizuuchi H; Sagae S; Moriwaka O; Tamagawa A
    Acta Cytol; 1990; 34(4):545-8. PubMed ID: 2375223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
    Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
    Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serous surface carcinoma of the peritoneum: useful role of cytology in differential diagnosis and follow-up.
    Tauchi PS; Caraway N; Truong LD; Kaplan AL; Ramzy I
    Acta Cytol; 1996; 40(3):429-36. PubMed ID: 8669174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
    Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
    Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary peritoneal carcinoma presenting on routine papanicolaou smear.
    Olsen TG; Nycum LR; Graham RL; Alagoz T
    Gynecol Oncol; 2000 Jul; 78(1):71-3. PubMed ID: 10873414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian carcinoma apparently confined to the ovaries--the accuracy of surgical staging in Israel.
    Menczer J; Chetrit A; Sadetzki S;
    Eur J Gynaecol Oncol; 2009; 30(4):375-8. PubMed ID: 19761125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of cytologic examination of peritoneal washings in patients with endometrial carcinoma.
    Szpak CA; Creasman WT; Vollmer RT; Johnston WW
    Acta Cytol; 1981; 25(6):640-6. PubMed ID: 6171978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma.
    Bozzetti C; Personeni N; Nizzoli R; Guazzi A; Flora M; Bassano C; Negri F; Martella E; Naldi N; Franciosi V; Cascinu S
    Cancer; 2003 Oct; 99(5):310-5. PubMed ID: 14579298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of proper staging in ovarian carcinoma.
    Piver MS
    Clin Obstet Gynaecol; 1983 Aug; 10(2):223-34. PubMed ID: 6617038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytopathology of peritoneal endometriosis caused by ruptured ovarian cysts.
    Kumar PV; Esfahani FN
    Acta Cytol; 1988; 32(4):523-6. PubMed ID: 3400393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma.
    Gadducci A; Viacava P; Cosio S; Cecchetti D; Fanelli G; Fanucchi A; Teti G; Genazzani AR
    Anticancer Res; 2003; 23(3C):3001-8. PubMed ID: 12926153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.